Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 7/2020

01-07-2020 | Septicemia | Letters of Biomedical and Clinical Research

Apolipoprotein C1 in synovial fluid discriminates septic arthritis from rheumatoid arthritis but not from pseudogout

Authors: Margot Clapasson, Candice Trocmé, Anais Courtier, Philippe Gaudin, Olivier Epaulard, Athan Baillet

Published in: Clinical Rheumatology | Issue 7/2020

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Coiffier G, David C, Gauthier P, Le Bars H, Guggenbuhl P, Jolivet-Gougeon A, Albert JD (2019) Broad-range 16 s rDNA PCR in synovial fluid does not improve the diagnostic performance of septic arthritis in native joints in adults: cross-sectional single-center study in 95 patients. Clin Rheumatol 38:1985–1992CrossRef
2.
Valour F, Bouaziz A, Karsenty J, Ader F, Lustig S, Laurent F et al (2014) Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort study. BMC Infect Dis 14:443CrossRef
3.
4.
Couderc M, Peyrode C, Pereira B, Miot-Noirault E, Mathieu S, Soubrier M et al (2019) Comparison of several biomarkers (MMP-2, MMP-9, the MMP-9 inhibitor TIMP-1, CTX-II, calprotectin, and COMP) in the synovial fluid and serum of patients with and without septic arthritis. Joint Bone Spine 86:261–262CrossRef
5.
Berbée JF, van der Hoogt CC, de Haas CJ, van Kessel KP, Dallinga-Thie GM, Romijn JA, Havekes LM, van Leeuwen H, Rensen PC (2008) Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis. Intensive Care Med 34:907–911CrossRef
6.
Berbée JF, Van der Hoogt CC, Kleemann R, Schippers EF, Kitchens RL, van Dissel JT et al (2006) Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J 20:2162–2164CrossRef
7.
Berbée JF, Mooijaart SP, de Craen AJ, Havekes LM, van Heemst D, Rensen PC et al (2008) Plasma apolipoprotein CI protects against mortality from infection in old age. J Gerontol A Biol Sci Med Sci 63:122–126CrossRef
8.
Harris HW, Gosnell JE, Kumwenda ZL (2000) The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 6:421–430PubMed
9.
Sack K (1997) Monarthritis: differential diagnosis. Am J Med 102(1A):30S–34SCrossRef
10.
Shah K, Spear J, Nathanson LA, McCauley J, Edlow JA (2007) Does the presence of crystal arthritis rule out septic arthritis? J Emerg Med 32(1):23–26CrossRef
Metadata
Title
Apolipoprotein C1 in synovial fluid discriminates septic arthritis from rheumatoid arthritis but not from pseudogout
Authors
Margot Clapasson
Candice Trocmé
Anais Courtier
Philippe Gaudin
Olivier Epaulard
Athan Baillet
Publication date
01-07-2020
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04912-8

Other articles of this Issue 7/2020

Clinical Rheumatology 7/2020 Go to the issue

Editorial

Navigating COVID-19 in the developing world

Letter to the Editor

Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis

Correction

Correction to: Associations between serumIL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis

Original Article

Serum adipokine levels in patients with sarcoidosis

Letters of Biomedical and Clinical Research

High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia

Editorial

The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits